Sixera Pharma AB
- Address
- Skeppsbron 16, Stockholms Domkyrkofors.
Sponsor Overview
Specializations
Genetic Skin Disorders
Sixera Pharma AB focuses on netherton syndrome, a rare inherited skin disorder characterized by impaired skin barrier function and chronic dermatologic symptoms.
- Netherton syndrome
- Rare dermatological disease
- Inherited skin barrier defects
Its clinical research is centered on therapeutic options for patients with severe, long-term cutaneous disease.
Topical Dermatologic Therapy
The sponsor is active in topical treatment development for affected skin areas, with interest in locally applied therapies designed for cutaneous symptoms and barrier restoration.
- Topical cream formulations
- Local skin-directed therapy
- Dermatologic symptom control
This area reflects a therapeutic emphasis on treatments intended for direct application to the skin in rare inflammatory and genetic conditions.
Clinical Safety and Efficacy in Rare Disease
Sixera Pharma AB’s trial activity includes evaluation of clinical safety and efficacy in patients with netherton syndrome, supporting development in a highly specialized rare-disease setting.
- Safety assessment
- Efficacy evaluation
- Rare disease patient care
The research interest lies in understanding therapeutic benefit and tolerability for a small patient population with significant unmet need.
Specialized Multicenter Dermatology Research
The sponsor works through multicenter clinical research involving sites across several countries, indicating activity in coordinated studies for uncommon dermatologic conditions.
- Multicenter trial network
- International site collaboration
- Specialist dermatology centers
This research environment supports access to patients with rare skin disease and focused clinical evaluation in expert treatment settings.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Safety and Efficacy of Topical SXR1096 Cream in Patients with Netherton Syndrome: A Phase I/II Randomized, Double-Blind, Placebo-Controlled Study |  Austria France Germany Sweden | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 5 sites across their trial portfolio.
Therapeutic Focus
- 1.Skin and Connective Tissue Diseases1 trial247 other sponsors
Partnered Research Centres
5 centres- Address
- Num Voie 47 A 83, 47 Boulevard De L Hopital, 75013 Paris
- Address
- 149 Rue De Sevres, 75015 Paris
- Address
- Byggnad R 8 01, 171 76 Stockholm
- Address
- Hugstetter Strasse 55, Stuehlinger, 79106 Freiburg im Breisgau
- Address
- Anichstrasse 35, 6020 Innsbruck
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Sixera Pharma AB.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.